XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Additional Paid-In Capital
Accumulated Deficit and Retained Earnings
Beginning balance (in shares) at Dec. 31, 2022   28,179    
Beginning balance at Dec. 31, 2022 $ 352,920 $ 282 $ 480,060 $ (127,422)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of stock on options exercised and restricted stock units vested (in shares)   658    
Issuance of stock on options exercised and restricted stock units vested 6 $ 6    
Share-based compensation 3,290   3,290  
Tax benefit from share-based compensation (15,373)   (15,373)  
Net income 11,630     11,630
Ending balance (in shares) at Mar. 31, 2023   28,837    
Ending balance at Mar. 31, 2023 $ 352,473 $ 288 467,977 (115,792)
Beginning balance (in shares) at Dec. 31, 2023 28,669 28,669    
Beginning balance at Dec. 31, 2023 $ 537,733 $ 287 475,970 61,476
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of stock on options exercised and restricted stock units vested (in shares)   280    
Issuance of stock on options exercised and restricted stock units vested 3 $ 3    
Share-based compensation 3,041   3,041  
Tax benefit from share-based compensation (5,881)   (5,881)  
Dividend payable (7,237)     (7,237)
Net income $ 41,963     41,963
Ending balance (in shares) at Mar. 31, 2024 28,949 28,949    
Ending balance at Mar. 31, 2024 $ 569,622 $ 290 $ 473,130 $ 96,202